Isolated human cell with an inactivated glucocorticoid receptor gene
Disclosed herein are methods and compositions for inactivation of the human glucocorticoid receptor (GR) gene by targeted cleavage of genomic DNA encoding the GR. Such methods and compositions are useful, for example, in therapeutic applications which require retention of immune function during glucocorticoid treatment.
1. An isolated human cell with an inactivated human glucocorticoid receptor (GR) gene, the isolated human cell comprising:
(i) a first zinc finger nuclease (ZFN) comprising a zinc finger DNA-binding domain comprising the following recognition helices in the following order:
TSRALTA (SEQ ID NO: 23);
DRANLSR (SEQ ID NO: 17);
RSDNLSE (SEQ ID NO: 24);
ERANRNS (SEQ ID NO:26); and
(ii) a second zinc finger nuclease (ZFN) comprising a zinc finger DNA-binding domain comprising the following recognition helices in the following order:
DSWNLQV (SEQ ID NO:33);
RSANLTR (SEQ ID NO: 27);
TSGNLTR (SEQ ID NO:30);
TSGSLTR (SEQ ID NO:31).
2. The isolated human cell of claim 1 comprising one or more polynucleotides encoding the first and second ZFNs.
3. The isolated human cell of claim 2 , wherein an expression vector comprises the one or more polynucleotides.
4. The isolated human cell of claim 3 , wherein the expression vector is a viral delivery vector.
5. The isolated human cell of claim 4 , wherein the viral delivery vector is an adenovirus, a hybrid adenovirus or a non-integrating lentivirus.
6. A method of making an isolated human hematopoietic cell or T-cell with a cleaved GR gene, the method comprising contacting an isolated human hematopoietic or T-cell cell with the one or more polynucleotides of claim 2 such that the endogenous GR gene is cleaved and inactivated.
7. The isolated human cell of claim 1 , wherein the cell is a T-cell or a hematopoietic cell.